(redirected from Intragastric Balloon)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Balloon Loan

A loan or bond in which the borrower makes only interest payments for a set period of time. At the end of the term, the borrower repays the entire principal at once. A balloon loan may be useful when the borrower expects interest rates to be low at the end of the term, allowing him/her simply to refinance the loan. However, there is a high risk of default because not all borrowers actually have the cash to repay an entire loan in one payment. See also: Balloon Mortgage.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved


The loan balance remaining at the time the loan contract calls for full repayment.

The Mortgage Encyclopedia. Copyright © 2004 by Jack Guttentag. Used with permission of The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The intragastric balloon - smoothing the path to bariatric surgery.
Intragastric balloon in the treatment of super-morbid obesity.
According to the company, this was the first procedure of its kind in Texas since the FDA approved the Orbera Intragastric Balloon System and the ReShape Integrated Dual Balloon System for use with weight loss patients in the US.
From 2005 to 2015, 135 obese patients with NAFLD received treatment with the BioEnterics Intragastric Balloon (BIB; Allergan, Goleta, CA, USA) at a single tertiary hospital (Guy's and St Thomas' Hospital, London, UK).
Apollo Endosurgery announced completion of enrollment in the ORBERA Post Approval Study evaluating the ORBERA intragastric balloon. The ORBERA Post Approval Study is a multi-center, open-label, prospective study of the safety and efficacy of the ORBERA system within the US.
M2 PHARMA-August 6, 2015-US FDA Clears Apollo Endosurgery Orbera Intragastric Balloon for Weight Loss
The saline-filled Bioenterics intragastric balloon (BIB) and the air-Idled Heliosphere intragastric balloon are in use in some European and South American countries, Mexico, and Canada, he said.
Apollo Endosurgery announced the presentation of results from Mayo Clinic's prospective open-label study of the Orbera Intragastric Balloon in patients with Nonalcoholic Steatohepatitis, or NASH, at Digestive Disease Week 2018.